Skip to content

Microvascular lesions in the brain: a new perspective on cognitive impairment in type 2 diabetes

Microvascular lesions in the brain: a new perspective on cognitive impairment in type 2 diabetes - Cerebral microvascular lesions in type 2 diabetes

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33315
Enrollment
140
Registered
2009-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age between 65 and 80 years diabetes patients: diagnosed with diabetes for more than 1 year

Exclusion criteria

Exclusion criteria: Dementia - TIA or non-invalidating stroke in the past 2 years or any invalidating stroke. - Other neurological diseases, unrelated to DM2, that are likely to affect cognition, including a history of brain trauma requiring hospitalisation - Known with or history of psychiatric disorders requiring hospitalisation or >12 months medication use (e.g. schizophrenia , Major depression (DSM IV)) - Contra-indication for 7 Tesla MR imaging (as established by the department)

Design outcomes

Primary

MeasureTime frame
The prevalence and total number of microinfarcts and microbleeds at 7T in relation to DM2 status and cognition.

Secondary

MeasureTime frame
Microvascular lesion load will be related to cognition, conventional MR markers (atrophy, white matter hyperintensities), diabetes status and vascular risk factors.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)